Sarier Mehmet, Duman Ibrahim, Kilic Suleyman, Yuksel Yucel, Demir Meltem, Aslan Mesut, Yucetin Levent, Tekin Sabri, Yavuz Asuman Havva, Emek Mestan
Department of Urology Kemerburgaz University Istanbul 34170 Turkey.
Department of Urology Liv Hospital Istinye University Istanbul 34120 Turkey.
Urol J. 2018 Jul 10;15(4):209-213. doi: 10.22037/uj.v0i0.4074.
The aim of this study is to compare the results of transurethral incision of the prostate (TUIP) and transurethral resection of the prostate (TURP) for the surgical treatment of benign prostate hyperplasia (BPH) in patients with renal transplantation.
Between April 2009 and May 2016, BPH patients with renal transplants whose prostate volumes were less than 30 cm3 were treated surgically. Forty-seven patients received TURP and 32 received TUIP. The patients' age, duration of dialysis, duration between transplant and TURP/TUIP, preoperative and postoperative serum creatinine (SCr), International Prostate Symptom Score (IPSS), maximum flow rate (Qmax) and postvoidresidual volume (PVR) were recorded. At 1-,6- and 12-month follow-up, early and long-term complications were assessed. Results were evaluated retrospectively.
In both groups, SCr, PVR and IPSS decreased significantly after the operation, while Qmax increased significantly (P < .001). There was no difference between the two groups in terms of increase in Qmax and decrease in IPSS, SCr and PVR (P = .89, P = .27, P = .08, and P = .27). Among postoperative complications, urinary tract infection (UTIs) and retrograde ejaculation (RE) rates were higher in the TURP group than the TUIP group (12.7% versus 6.2% and 68.1% versus 25%,respectively), whereas urethral strictures were more prevalent in the TUIP group (12.5% versus 6.3%).
For the treatment of BPH in renal transplant patients with a prostate volume less than 30 cm3, bothTUIP and TURP are safe and effective.
本研究旨在比较经尿道前列腺切开术(TUIP)和经尿道前列腺切除术(TURP)治疗肾移植患者良性前列腺增生(BPH)的效果。
2009年4月至2016年5月,对前列腺体积小于30 cm³的肾移植BPH患者进行手术治疗。47例患者接受TURP,32例接受TUIP。记录患者的年龄、透析时间、移植与TURP/TUIP之间的时间、术前和术后血清肌酐(SCr)、国际前列腺症状评分(IPSS)、最大尿流率(Qmax)和残余尿量(PVR)。在1个月、6个月和12个月随访时,评估早期和长期并发症。对结果进行回顾性评估。
两组患者术后SCr、PVR和IPSS均显著下降,而Qmax显著增加(P <.001)。两组在Qmax增加以及IPSS、SCr和PVR下降方面无差异(P =.89、P =.27、P =.08和P =.27)。术后并发症中,TURP组的尿路感染(UTIs)和逆行射精(RE)发生率高于TUIP组(分别为12.7%对6.2%和68.1%对25%),而尿道狭窄在TUIP组更为普遍(12.5%对6.3%)。
对于前列腺体积小于30 cm³的肾移植患者BPH的治疗,TUIP和TURP均安全有效。